DaVita Director Awarded Routine Stock Grant
DAVITA INC.
Subscribe to track DVA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
DaVita Director Awarded Routine Stock Grant
Company: DaVita Inc. (DVA) Form: 4 | Filed: 2025-11-17 Significance: Low
Insider: YALE PHYLLIS R Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 411 • Price: $0.00 • Value: $0 • Owned After: 13,981
Key Insight: A routine, non-cash stock award to a director as part of their compensation package, with negligible market impact.
Market Context: This grant represents a minimal 0.0006% of shares outstanding for the $8.58B healthcare services company.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: DAVITA INC. (DVA)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine, non-cash stock award as part of their compensation, a common practice with no immediate market implications.
- Market Impact: Negligible. The transaction has a value of $0 and represents an insignificant portion of the company's shares outstanding.
Company Information
| Field | Value |
|---|---|
| Company | DAVITA INC. |
| Ticker Symbol | DVA |
| CIK | 0000927066 |
| Industry | Services-Misc Health & Allied Services, NEC |
Insider Information
| Field | Value |
|---|---|
| Name | YALE PHYLLIS R |
| CIK | 0001269070 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-15 |
| Transaction Code | A (Award) |
| Security Type | Common Stock |
| Shares Involved | 411 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 13,981 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 411 |
| % of Shares Outstanding | 0.0006% |
| Post-Transaction Ownership | 13,981 shares (0.0196% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction has no monetary value and is immaterial against DaVita's $8.58 billion market capitalization.
- Ownership Concentration: The director's post-transaction ownership remains very low at approximately 0.02% of total shares outstanding.
- Dilution Impact: The issuance of 411 new shares has a negligible dilutive effect (0.0006%) on existing shareholders.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a standard compensation-related stock grant with a $0 transaction value. It does not signal any new insider sentiment regarding the company's future performance.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is a non-market award and will not affect trading volume.
- Sentiment Indicator: Neutral. This type of filing is routine and typically ignored by the market.
Additional Context
Transaction Notes
- The transaction is coded 'A' for Award, indicating it is a grant of stock from the company to the insider, not an open market purchase.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.